Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sodium Zirconium Cyclosilicate Powder

Approval Number

国药准字HJ20190073

CompanyASTRAZENECA AB

Registration Date

May 31, 2024

Previous Approval Numbers

H20190073

Drug Information

Generic Name

环硅酸锆钠散

Trade Name

利倍卓

Dosage Form

散剂

Strength

10g

Drug Type

化学药品

Registration Date

May 31, 2024

Expiry Date

May 30, 2029

Company Information

Applicant Company

Company NameASTRAZENECA AB

Company Address

SE-151 85 Sodertalje, Sweden

Manufacturing Company

Company NameAndersonBrecon, Inc.

Company Address

4545 Assembly Drive, Rockford, Illinois, 61109, USA

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

环硅酸锆钠散 - NMPA 批准文号 | MedPath